Claritev (CTEV) Q2 Revenue Rises 4%

Claritev (NYSE:CTEV), a healthcare data analytics and cost management company, reported its second quarter 2025 earnings on August 6, 2025. The standout news is revenue rising to $241.6 million (GAAP) in Q2 2025, which exceeded analyst estimates by $10.2 million (GAAP). However, the company reported a net loss of $(3.81) per share (GAAP) in Q2 2025, much lower than expectations (GAAP EPS). While free cash flow (non-GAAP) moved back into positive territory, and the underlying business showed signs of progress, the quarter was marked by continued bottom-line losses and higher general and administrative expenses. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Claritev is a provider of analytics-driven solutions for the healthcare industry. Its services help insurance companies, healthcare providers, and employers reduce the cost of medical claims by utilizing advanced data analytics. The company’s platform uses algorithms and claims analysis to identify overcharges and inefficiencies, helping clients lower their medical spend.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool